Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
PLoS One. 2012;7(6):e37915. doi: 10.1371/journal.pone.0037915. Epub 2012 Jun 7.
Biopharmaceuticals represent the fastest growing sector of the global pharmaceutical industry. Cost-efficient production of these biologic drugs requires a robust host organism for generating high titers of protein during fermentation. Understanding key cellular processes that limit protein production and secretion is, therefore, essential for rational strain engineering. Here, with single-cell resolution, we systematically analysed the productivity of a series of Pichia pastoris strains that produce different proteins both constitutively and inducibly. We characterized each strain by qPCR, RT-qPCR, microengraving, and imaging cytometry. We then developed a simple mathematical model describing the flux of folded protein through the ER. This combination of single-cell measurements and computational modelling shows that protein trafficking through the secretory machinery is often the rate-limiting step in single-cell production, and strategies to enhance the overall capacity of protein secretion within hosts for the production of heterologous proteins may improve productivity.
生物制药是全球制药行业增长最快的领域。这些生物药物的成本效益生产需要一个强大的宿主生物体,以便在发酵过程中产生高浓度的蛋白质。因此,了解限制蛋白质生产和分泌的关键细胞过程对于合理的菌株工程至关重要。在这里,我们以单细胞分辨率系统地分析了一系列毕赤酵母菌株的生产力,这些菌株分别组成型和诱导型生产不同的蛋白质。我们通过 qPCR、RT-qPCR、微刻和成像细胞术对每种菌株进行了表征。然后,我们开发了一个简单的数学模型来描述折叠蛋白通过 ER 的通量。单细胞测量和计算建模的这种组合表明,蛋白质通过分泌机制的运输通常是单细胞生产中的限速步骤,并且提高宿主中异源蛋白质分泌的整体能力的策略可能会提高生产力。